Differential effects of myopathy-associated caveolin-3 mutants on growth factor signaling

American Journal of Pathology

Volumn 177, Issue 1, 2010, Pages 261-270

  Brauers, Eva ^a   Dreier, Agnes ^a   Roos, Andreas ^a   Wormland, Berthold ^b   Weis, Joachim ^a   Krüttgen, Alexander ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Klinikum Duisburg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 3; DYSTROPHIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A;

ADULT; ANIMAL CELL; ARTICLE; BIOTINYLATION; CASE REPORT; CELL STRAIN; CELL STRAIN 3T3; CELL STRAIN HEK293; COMPARATIVE STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MOUSE; MUSCLE INJURY; MYOBLAST; MYOPATHY; NERVE CELL; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 77954609322     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090741     Document Type: Article

References (53)

1. Lisanti MP, Sargiacomo M, Scherer PE: Purification of caveolae-derived membrane microdomains containing lipid-anchored signaling molecules, such as GPI-anchored proteins. H-Ras, Src-family tyrosine kinases, eNOS, and G-protein alpha-, beta-, and gamma-subunits. Methods Mol Biol 1999, 116:51-60
2. Way M, Parton RG: M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 1996, 378:108-112
3. Vorgerd M, Ricker K, Ziemssen F, Kress W, Goebel HH, Nix WA, Kubisch C, Schoser BG, Mortier W: A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 2001, 57:2273-2277
4. Herrmann R, Straub V, Blank M, Kutzick C, Franke N, Jacob EN, Lenard HG, Kroger S, Voit T: Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 2000, 9:2335-2340
5. Sotgia F, Woodman SE, Bonuccelli G, Capozza F, Minetti C, Scherer PE, Lisanti MP: Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease. Am J Physiol Cell Physiol 2003, 285:C1150-C1160 (Pubitemid 37296292)
6. Merlini L, Carbone I, Capanni C, Sabatelli P, Tortorelli S, Sotgia F, Lisanti MP, Bruno C, Minetti C: Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 2002, 73:65-67
7. McNally EM, de Sa Moreira E, Duggan DJ, Bonnemann CG, Lisanti MP, Lidov HG, Vainzof M, Passos-Bueno MR, Hoffman EP, Zatz M, Kunkel LM: Caveolin-3 in muscular dystrophy. Hum Mol Genet 1998, 7:871-877
8. Felberbaum-Corti M, Van Der Goot FG, Gruenberg J: Sliding doors: clathrin-coated pits or caveolae? Nat Cell Biol 2003, 5:382-384
9. Carozzi AJ, Roy S, Morrow IC, Pol A, Wyse B, Clyde-Smith J, Prior IA, Nixon SJ, Hancock JF, Parton RG: Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin-3. J Biol Chem 2002, 277:17944-17949
10. Traverso M, Gazzerro E, Assereto S, Sotgia F, Biancheri R, Stringara S, Giberti L, Pedemonte M, Wang X, Scapolan S, Pasquini E, Donati MA, Zara F, Lisanti MP, Bruno C, Minetti C: Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Lab Invest 2008, 88:275-283
11. Weis J, Kaussen M, Calvo S, Buonanno A: Denervation induces a rapid nuclear accumulation of MRF4 in mature myofibers. Dev Dyn 2000, 218:438-451 (Pubitemid 30460513)
12. Saxena S, Howe CL, Cosgaya JM, Steiner P, Hirling H, Chan JR, Weis J, Kruttgen A: Differential endocytic sorting of p75NTR and TrkA in response to NGF: a role for late endosomes in TrkA trafficking. Mol Cell Neurosci 2005, 28:571-587
13. Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B, Roth BL: Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem 2004, 279:34614-34623
14. Wharton J, Meshulam T, Vallega G, Pilch P: Dissociation of insulin receptor expression and signaling from caveolin-1 expression. J Biol Chem 2005, 280:13483-13486 (Pubitemid 40517238)
15. Sotgia F, Bonuccelli G, Minetti C, Woodman SE, Capozza F, Kemp RG, Scherer PE, Lisanti MP: Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. Am J Pathol 2003, 163:2619-2634
16. Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP: Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C): retention of LGMD-1C caveolin-3 mutants within the golgi complex. J Biol Chem 1999, 274:25632-25641 (Pubitemid 129530737)
17. Shin T, Kim H, Jin JK, Moon C, Ahn M, Tanuma N, Matsumoto Y: Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 2005, 165:11-20
18. Nishiyama K, Trapp BD, Ikezu T, Ransohoff RM, Tomita T, Iwatsubo T, Kanazawa I, Hsiao KK, Lisanti MP, Okamoto T: Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease. J Neurosci 1999, 19:6538-6548
19. Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, Serizawa H, Lane WS, Lisanti MP, Okamoto T: Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Res 1998, 804:177-192
20. Oderfeld-Nowak B, Orzylowska-Sliwinska O, Soltys Z, Zaremba M, Januszewski S, Janeczko K, Mossakowski M: Concomitant up-regulation of astroglial high and low affinity nerve growth factor receptors in the CA1 hippocampal area following global transient cerebral ischemia in rat. Neuroscience 2003, 120:31-40
21. Aguado F, Ballabriga J, Pozas E, Ferrer I: TrkA immunoreactivity in reactive astrocytes in human neurodegenerative diseases and colchicine-treated rats. Acta Neuropathol 1998, 96:495-501
22. Rende M, Brizi E, Conner J, Treves S, Censier K, Provenzano C, Taglialatela G, Sanna PP, Donato R: Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int J Dev Neurosci 2000, 18:869-885
23. Shibayama E, Koizumi H: Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am J Pathol 1996, 148:1807-1818
24. Segal RA, Greenberg ME: Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 1996, 19:463-489
25. Peiro S, Comella JX, Enrich C, Martin-Zanca D, Rocamora N: PC12 cells have caveolae that contain TrkA: caveolae-disrupting drugs inhibit nerve growth factor-induced, but not epidermal growth factor-induced, MAPK phosphorylation. J Biol Chem 2000, 275:37846-37852 (Pubitemid 32004902)
26. Bilderback TR, Gazula VR, Lisanti MP, Dobrowsky RT: Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways. J Biol Chem 1999, 274:257-263
27. Volonte D, McTiernan CF, Drab M, Kasper M, Galbiati F: Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis. Am J Physiol Heart Circ Physiol 2008, 294:H392-H401
28. Moises T, Dreier A, Flohr S, Esser M, Brauers E, Reiss K, Merken D, Weis J, Kruttgen A: Tracking TrkA's trafficking: nGF receptor trafficking controls NGF receptor signaling. Mol Neurobiol 2007, 35:151-159 (Pubitemid 350131692)
29. Bronfman FC, Escudero CA, Weis J, Kruttgen A: Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev Neurobiol 2007, 67:1183-1203 (Pubitemid 47229867)
30. Saxena S, Bucci C, Weis J, Kruttgen A: The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA. J Neurosci 2005, 25:10930-10940 (Pubitemid 41692623)
31. Moises T, Wuller S, Saxena S, Senderek J, Weis J, Kruttgen A: Proteasomal inhibition alters the trafficking of the neurotrophin receptor TrkA. Biochem Biophys Res Commun 2009, 387:360-364
32. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984, 309:418-425 (Pubitemid 14102443)
33. Kiel C, Serrano L: Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling. Sci Signal 2009, 2:ra38
34. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000, 1:31-39
35. Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP: Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 2004, 62:538-543 (Pubitemid 38252792)
36. Paratcha G, Ibanez CF: Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme. Curr Opin Neurobiol 2002, 12:542-549 (Pubitemid 35284089)
37. Evangelopoulos ME, Weis J, Kruttgen A: Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: hDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene 2005, 24:3309-3318
38. Couet J, Sargiacomo M, Lisanti MP: Interaction of a receptor tyrosine kinase, EGF-R, with caveolins Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 1997, 272:30429-30438
39. Mineo C, Gill GN, Anderson RG: Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem 1999, 274:30636-30643
40. Wang XQ, Yan Q, Sun P, Liu JW, Go L, McDaniel SM, Paller AS: Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Cancer Res 2007, 67:9986-9995
41. McGuire JF, Rouen S, Siegfreid E, Wright DE, Dobrowsky RT: Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy. Diabetes 2009, 58:2677-2686
42. Savas S, Geraci J, Jurisica I, Liu G: A comprehensive catalogue of functional genetic variations in the EGFR pathway: protein-protein interaction analysis reveals novel genes and polymorphisms important for cancer research. Int J Cancer 2009, 125:1257-1265
43. Dobrowsky RT, Rouen S, Yu C: Altered neurotrophism in diabetic neuropathy: spelunking the caves of peripheral nerve. J Pharmacol Exp Ther 2005, 313:485-491
44. Panayotatos N, Radziejewska E, Acheson A, Pearsall D, Thadani A, Wong V: Exchange of a single amino acid interconverts the specific activity and gel mobility of human and rat ciliary neurotrophic factors. J Biol Chem 1993, 268:19000-19003
45. Sorkin A: TRKing signals through the Golgi. Sci STKE 2005, 2005:pe1
46. de Paula F, Vainzof M, Bernardino AL, McNally E, Kunkel LM, Zatz M: Mutations in the caveolin-3 gene: when are they pathogenic? Am J Med Genet 2001, 99:303-307
47. Lajoie P, Partridge EA, Guay G, Goetz JG, Pawling J, Lagana A, Joshi B, Dennis JW, Nabi IR: Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol 2007, 179:341-356
48. den Hartigh JC, van Bergen en Henegouwen PM, Boonstra J, Verkleij AJ: Cholesterol and phosphoinositides increase affinity of the epidermal growth factor receptor. Biochim Biophys Acta 1993, 1148:249-256
49. Capanni C, Sabatelli P, Mattioli E, Ognibene A, Columbaro M, Lattanzi G, Merlini L, Minetti C, Maraldi NM, Squarzoni S: Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition. Exp Mol Med 2003, 35:538-544
50. Chen X, Raab G, Deutsch U, Zhang J, Ezzell RM, Klagsbrun M: Induction of heparin-binding EGF-like growth factor expression during myogenesis: activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. J Biol Chem 1995, 270:18285-18294
51. Carlson BM, Carlson JA, Dedkov EI, McLennan IS: Concentration of caveolin-3 at the neuromuscular junction in young and old rat skeletal muscle fibers. J Histochem Cytochem 2003, 51:1113-1118
52. Ip FC, Cheung J, Ip NY: The expression profiles of neurotrophins and their receptors in rat and chicken tissues during development. Neurosci Lett 2001, 301:107-110
53. Pitts EV, Potluri S, Hess DM, Balice-Gordon RJ: Neurotrophin and Trk-mediated signaling in the neuromuscular system. Int Anesthesiol Clin 2006, 44(2):21-76